Incorporating a psychological counselor in a cancer risk assessment program: Necessity, acceptability, and potential roles

Journal of Genetic Counseling

Volumn 11, Issue 1, 2002, Pages 51-64

  Matthews, Alicia K ^a   Brandenburg, Dana L ^b   Cummings, Shelly ^a   Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Illinois School of Professional Psychology   (United States)

Author keywords

Cancer risk counseling; Genetic counseling; Mental health counseling

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; COUNSELING; DEPRESSION; DISTRESS SYNDROME; FEMALE; GENETIC COUNSELING; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MALE; MEDICAL PERSONNEL; PSYCHOLOGIST; RISK ASSESSMENT; STRESS; SUICIDE ATTEMPT;

EID: 3543082105     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1023/A:1013820515603     Document Type: Article

References (35)

1. Audrain J, Rimer B, Cella D, Stefanek M, Garber J, Pennanen M, Helzlsouer K, Vogel V, Lin TH, Lerman C (1999) The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. Psychooncology 8:220-229.
2. Audrain J, Schwartz MD, Lerman C, Hughes C, Peshkin BN, Biesecker B (1997) Psychological-distress in women seeking genetic counseling for breast ovarian cancer risk: The contributions of personality and appraisal. Ann Behav Med 19:370-377.
3. Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins JE, Weber BL (1993) Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269:1970-1974.
4. Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Rejan K, Schildkraudt J, Winer EP (1999) Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 17:1040-1046.
5. Carver CS, Pozo-Kaderman C, Price AA, Noriega V, Harris SD, Derhagopian RP, Robinson DS, Moffat FL, Jr (1998) Concerns about aspects of body image and adjustment to early stage breast cancer. Psychosom Med 60:168-174.
6. Coyne JC, Benazon NR, Gaba CG, Calzone K, Weber BL (2000) Distress and psychiatric morbidity among women from high risk breast and ovarian cancer families. J Consult Clin Psychol 68:864-874.
7. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J (1997) Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol 16:63-72.
8. France L, Gray J, Elwyn G, Tischkowitz M, Brain K, Sampson J, Anglim C, Clarke A, Parsons E, Sweetland H, Mansel R, Barret-Lett P, Harper P (1999) Genetic testing considerations in breast cancer patients. J Genet Counsel 8:289-299.
9. Gatz M, Harris JR, Turk-Charles S (1995) The meaning of health in older women. In: Stanton AL, Gallant S (eds) The Psychology of Women's Health: Progress and Challenges in Research and Application. Washington, DC: American Psychological Association, pp 491-529.
10. Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S (2001) Factors influencing patients'decisions to decline cancer genetic counseling services. J Genet Counsel 10:25-40.
11. Horowitz M, Wilner N, Alvarez W (1979) Impact of Event Scale: A measure of subjective distress. Psychosom Med 41:209-218.
12. Jones KR, Bronheim S, Veach PM, Gray CA, Goreczny A, Hoss M, Lopez M (2000) The coming revolution of health care: Implications of the human genome project for health psychologists. Health Psychol 22:6-7, 19.
13. Kash KM, Holland JC, Halper MS (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 85:24-30.
14. Lerman C, Croyle R (1994) Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 154:609-616.
15. Lerman C, Rimer B, Engstrom P (1991) Cancer risk notification: Psychosocial and ethical considerations. J Clin Oncol 9:1275-1282.
16. Lerman C, Hughes C, Leman SJ, Main D, Snyder C, Durham C, Nard S, Lynch HT (1998) What you don't know can hurt you: Adverse psychological effects in members of BRCA/-linked and SRCA2-linked families who decline genetic testing. J Clin Oncol 16:1650-1654.
17. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Blashem A (1995) Effects of individualized breast cancer risk counseling: A randomized trial. J Natl Cancer Inst 87:286-292.
18. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H (1996) BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275:1885-1892.
19. Lerman C, Rimer B, Glynn T (1997a) Priorities in behavioral research in cancer prevention and control. Prev Med 26:S3-S9.
20. Lerman C, Schwartz MD (1993) Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 28:145-155.
21. Lerman C, Schwartz MD, Lin TH, Hughes C, Narod S, Lynch HT (1997b) The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 65:414-420.
22. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A (1991) Psychological side effects of breast cancer screening. Health Psychol 10:259-267.
23. McCaul KD, Branstetter AD, O'Donnell SM, Jacobson K, Quinlan KB (1998) A descriptive study of breast cancer worry. J Behav Med 21:565-579.
24. Miki Y, Swense J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 226:66-71.
25. Mirowsky J, Ross CE (1990) Control or defense? Depression and the sense of control over good and bad outcomes. J Health Soc Behav 31:71-86.
26. Pasacreta J (1999) Psychosocial issues associated with increased breast and ovarian cancer risk: Findings from focus groups. Arch Psychiatr Nurs 3:127-136.
27. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 muationsin a population of 649 women with ovarian cancer. Am J Hum Genet 68:700-710.
28. Salkovskis PM, Rimes KA (1997) Predictive genetic testing: Psychological factors. J Psychosom Res 43:477-487.
29. Schwartz M, Lerman C, Daly M, Audrain J, Masny A, Griffith K (1995) Utilization of ovarian cancer screening by women at increased risk. Cancer Epidemiol Biomarkers Prev 4:269-273.
30. Schwartz MD, Lerman C, Audrain J, Cella D, Rimer B, Stefanek M, Garber J, Lin Hosing T, Vogel V (1998) The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med 20:7-13.
31. Shoda Y, Mischel W, Miller SM, Diefenback M, Daly MB, Engstrom PF (1998) Psychological interventions and genetic testing: Facilitating informed decisions about BRCA1/2 cancer susceptibility. J Clin Psychol Med Settings 5:3-17.
32. Spiegel D (1996) Cancer and depression. Br J Psychiatry 168:109-116.
33. Stefanek ME, Wilcox P (1991) First-degree relatives of breast cancer patients: Screening practices and provision of risk information. Cancer Detect Prev 15:379-384.
34. Stewart AL, Hays RD, Ware JE (1988) The MOS Short-form General Health Survey: Reliability and validity in a patient population. Med Care 26:724-735.
35. Wooster R, Bignell G, Lancaster J, Swift S, Gregory S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.